» Authors » Si-Yuan Li

Si-Yuan Li

Explore the profile of Si-Yuan Li including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 69
Citations 644
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Li S, Cao W, Ge Y, Lvy W, Liu Y, Qin L
Heliyon . 2025 Mar; 11(4):e42408. PMID: 40028518
Hyperimmunoglobulin E syndrome (HIES) is a rare primary immunodeficiency disorder characterized by recurrent infections, severe eczema, and elevated serum immunoglobulin E (IgE) levels. Genetic testing traditionally focuses on known genes...
2.
Li S, Li S, Gao Y, Gao Y, Dang Y, Zhang L, et al.
Turk J Haematol . 2025 Feb; 42(1):1-8. PMID: 39935291
Objective: TAFRO syndrome, entailing thrombocytopenia, anasarca, fever, reticulin fibrosis, and organomegaly, was previously considered a subtype of idiopathic multicentric Castleman disease (iMCD-TAFRO), with the diagnosis requiring pathology supporting Castleman disease....
3.
Gao Y, Yao J, Li S, Dang Y, Xu H, Zou T, et al.
Am J Hematol . 2025 Jan; 100(3):539-541. PMID: 39752292
No abstract available.
4.
Zhu Y, Qi Y, Yang J, Luo M, Sun Y, Li S, et al.
Zhongguo Zhong Yao Za Zhi . 2024 Dec; 49(21):5877-5887. PMID: 39701797
Based on the differences in the protective effects of fresh Panax ginseng and its processed products on myocardial ischemia in mice, this study identified the advantageous aspects of fresh P....
5.
Gao Y, Li S, Dang Y, Duan M, Zhang L, Li J
Br J Haematol . 2024 Oct; 206(1):152-158. PMID: 39406386
Idiopathic multicentric Castleman disease (iMCD) is a rare and heterogeneous lymphoproliferative disorder that lacks standardised treatment options for patients with refractory or relapsed (r/r) disease. Blocking Bruton's tyrosine kinase (BTK)...
6.
Wang X, Wang Z, Chen H, Luo Y, Li S, Luo X, et al.
Heliyon . 2024 Sep; 10(17):e37230. PMID: 39286117
Background: SZ-685C, an anthracycline compound derived from the mangrove endophytic fungus sp. (No. 1403) collected from the South China Sea, has shown strong anticancer activities. Non-functioning pituitary adenomas (NFPAs) are...
7.
Li S, Guo J, Yang Y
J Asian Nat Prod Res . 2024 Jun; 26(11):1328-1338. PMID: 38945152
Histone deacetylase 6 (HDAC6) was a potential target for Alzheimer's disease (AD). In this study, a series of novel oxyevodiamine-based HDAC6 inhibitors with a variety of linker moieties were designed,...
8.
Zhang L, Gao Y, Li S, Zhao H, Zhang M, Yu Y, et al.
Int J Hematol . 2024 Mar; 119(6):631-637. PMID: 38546960
Relapsed and refractory (R/R) idiopathic multicentric Castleman disease (iMCD) is a clinical challenge with no standard treatment. In this preliminary clinical trial, we investigated the efficacy and safety profiles of...
9.
Gao Y, Liu Y, Zhang M, Li S, Fajgenbaum D, Zhang L, et al.
Br J Haematol . 2024 Feb; 204(5):1830-1837. PMID: 38356434
Idiopathic multicentric Castleman disease (iMCD) is subclassified into iMCD-thrombocytopenia, anasarca, reticulin fibrosis, renal dysfunction, organomegaly (TAFRO) and iMCD-not otherwise specified (NOS) according to the Castleman Disease Collaborative Network (CDCN) consensus...
10.
Chen C, Lin C, Pei Y, Ma D, Liao L, Li S, et al.
Cell Discov . 2023 Dec; 9(1):125. PMID: 38114467
Germline-somatic mutation interactions are universal and associated with tumorigenesis, but their role in breast cancer, especially in non-Caucasians, remains poorly characterized. We performed large-scale prospective targeted sequencing of matched tumor-blood...